International Seven Journal of Health Research
##common.pageHeaderLogo.altText##
##common.pageHeaderLogo.altText##

e-ISSN: 2764-9415



Contact

  • Seven Publicações Ltda CNPJ: 43.789.355/0001-14 Rua: Travessa Aristides Moleta, 290- São José dos Pinhais/PR CEP: 83045-090
  • Principal Contact
  • Nathan Albano Valente
  • (41) 9 8836-2677
  • contato@sevenpublicacoes.com.br
  • Support Contact
  • contato@sevenpublicacoes.com.br

Complete genome sequencing of Mycobacterium Tuberculosis in the identification of gene mutations associated with antimicrobial resistance

Prina Rocha I;
Valois Cunha C;
Paula Furtado Carneiro da Fontoura A;
Sinnott Dias R;
da Cruz Goulart I;
Fontoura Perim L;
Klein de Almeida de Chaves AC

Iago Prina Rocha

Caroline Valois Cunha

Ana Paula Furtado Carneiro da Fontoura

Rafaela Sinnott Dias

Ivana da Cruz Goulart

Laura Fontoura Perim

Ana Claudia Klein de Almeida de Chaves


Keywords

Genome
Antibiotics
Tuberculosis
Genoma
Antibióticos
Tuberculose.

Abstract

The development and application of new molecular tools has shown the real complexity involved in Mycobacterium Tuberculosis infection. The sequencing of the complete Koch's Bacillus genome can reveal information about the true extent of the point mutations that confer resistance to treatment to these bacteria. Complete genome sequencing techniques and their availability in public databases, have been responsible for the exponential growth of computational tools to extract information about important features encoded in the genomes of Mycobacterium complex species. This is a literature review study, from scientific research platforms, with the aim of discussing how computational tools used for analysis of the complete genome sequencing of M. tuberculosis can identify the genetic relationship between strain mutations and antimicrobial resistance. Whole genome sequencing is considered a surveillance marker of transmission and drug resistance, as well as a strong predictor of the emergence of possible resistance mechanisms for first- and second-line drugs used in the treatment of pulmonary tuberculosis.


Author(s)

  • Iago Prina Rocha
  • Caroline Valois Cunha
  • Ana Paula Furtado Carneiro da Fontoura
  • Rafaela Sinnott Dias
  • Ivana da Cruz Goulart
  • Laura Fontoura Perim
  • Ana Claudia Klein de Almeida de Chaves